SI2137196T1 - Tricikliäśne spojine, ki vsebujejo duĺ ik, uporabne kot antibakterijska sredstva - Google Patents

Tricikliäśne spojine, ki vsebujejo duĺ ik, uporabne kot antibakterijska sredstva

Info

Publication number
SI2137196T1
SI2137196T1 SI200830103T SI200830103T SI2137196T1 SI 2137196 T1 SI2137196 T1 SI 2137196T1 SI 200830103 T SI200830103 T SI 200830103T SI 200830103 T SI200830103 T SI 200830103T SI 2137196 T1 SI2137196 T1 SI 2137196T1
Authority
SI
Slovenia
Prior art keywords
compounds containing
containing human
antibacterial functions
tricycle
tricycle compounds
Prior art date
Application number
SI200830103T
Other languages
English (en)
Slovenian (sl)
Inventor
David Evan Davies
David Thomas Davies
Ilaria Giordano
Alan Joseph Hennessy
Neil David Pearson
Original Assignee
Glaxo Group Ltd Glaxo Welcome House
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2137196(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0707705A external-priority patent/GB0707705D0/en
Priority claimed from GB0720569A external-priority patent/GB0720569D0/en
Priority claimed from GB0805311A external-priority patent/GB0805311D0/en
Application filed by Glaxo Group Ltd Glaxo Welcome House filed Critical Glaxo Group Ltd Glaxo Welcome House
Publication of SI2137196T1 publication Critical patent/SI2137196T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI200830103T 2007-04-20 2008-04-16 Tricikliäśne spojine, ki vsebujejo duĺ ik, uporabne kot antibakterijska sredstva SI2137196T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0707705A GB0707705D0 (en) 2007-04-20 2007-04-20 Compounds
GB0720569A GB0720569D0 (en) 2007-10-19 2007-10-19 Compounds
GB0805311A GB0805311D0 (en) 2008-03-20 2008-03-20 Compounds
PCT/EP2008/054621 WO2008128942A1 (en) 2007-04-20 2008-04-16 Tricyclic nitrogen containing compounds as antibacterial agents
EP08749580A EP2137196B1 (en) 2007-04-20 2008-04-16 Tricyclic nitrogen containing compounds as antibacterial agents

Publications (1)

Publication Number Publication Date
SI2137196T1 true SI2137196T1 (sl) 2011-01-31

Family

ID=39580226

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830103T SI2137196T1 (sl) 2007-04-20 2008-04-16 Tricikliäśne spojine, ki vsebujejo duĺ ik, uporabne kot antibakterijska sredstva

Country Status (31)

Country Link
US (1) US8389524B2 (enExample)
EP (1) EP2137196B1 (enExample)
JP (1) JP5389013B2 (enExample)
KR (1) KR101567096B1 (enExample)
CN (1) CN101687887B (enExample)
AR (1) AR066111A1 (enExample)
AT (1) ATE483717T1 (enExample)
AU (1) AU2008240764C1 (enExample)
BR (1) BRPI0810064B8 (enExample)
CA (1) CA2684659C (enExample)
CL (1) CL2008001122A1 (enExample)
CO (1) CO6251368A2 (enExample)
CR (2) CR11123A (enExample)
CY (1) CY1111248T1 (enExample)
DE (1) DE602008002912D1 (enExample)
DK (1) DK2137196T3 (enExample)
DO (1) DOP2009000240A (enExample)
EA (1) EA015821B1 (enExample)
HR (1) HRP20100574T1 (enExample)
IL (1) IL201204A0 (enExample)
MA (1) MA31324B1 (enExample)
MX (1) MX2009011317A (enExample)
MY (1) MY149347A (enExample)
NZ (1) NZ579877A (enExample)
PE (1) PE20090274A1 (enExample)
PL (1) PL2137196T3 (enExample)
PT (1) PT2137196E (enExample)
SI (1) SI2137196T1 (enExample)
TW (1) TWI431006B (enExample)
UY (1) UY31038A1 (enExample)
WO (1) WO2008128942A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1954697B1 (en) * 2005-10-21 2010-02-24 Glaxo Group Limited Peri condensed tricyclic compounds useful as antibacterial agents
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
EP2205609B1 (de) 2007-10-19 2017-03-29 Boehringer Ingelheim International GmbH Heterocyclus-substituierte piperazino-dihydrothienopyrimidine
EP2215093B1 (de) 2007-10-19 2011-12-14 Boehringer Ingelheim International GmbH Neue piperazino-dihydrothienopyrimidin-derivate
JP5150728B2 (ja) 2007-10-19 2013-02-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピペリジノ−ジヒドロチエノピリミジン
MX2010008922A (es) 2008-02-20 2010-09-07 Actelion Pharmaceuticals Ltd Compuestos antibioticos azatriciclicos.
MX2010012732A (es) * 2008-05-23 2010-12-07 Glaxo Group Ltd Compuestos que contienen nitrogeno triciclico y su uso como antibacterianos.
WO2009141399A1 (en) * 2008-05-23 2009-11-26 Glaxo Group Limited Tricyclic nitrogen containing compounds and their use as antibacterials
MY158520A (en) 2008-10-07 2016-10-14 Actelion Pharmaceuticals Ltd Tricyclic oxazolidinone antibiotic compounds
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
CA2749163A1 (en) 2009-01-14 2010-07-22 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
NZ603268A (en) * 2010-05-04 2015-02-27 Alkermes Pharma Ireland Ltd Process for synthesizing oxidized lactam compounds
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CN103113291B (zh) * 2013-02-04 2015-03-04 浙江大学 一种3位烯基吡啶衍生物的合成方法
US9975910B2 (en) 2013-07-23 2018-05-22 Eisai R&D Management Co., Ltd. Hetero-fused cyclic compound
WO2016027249A1 (en) * 2014-08-22 2016-02-25 Glaxosmithkline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
KR102474326B1 (ko) * 2016-06-22 2022-12-05 반더빌트유니버시티 무스카린성 아세틸콜린 수용체 m4의 양성 알로스테릭 조절제
WO2018195098A1 (en) 2017-04-17 2018-10-25 Ohio State Innovation Foundation Type ii topoisomerase inhibitors and methods of making and using thereof
EP3946342A1 (en) 2019-04-03 2022-02-09 GlaxoSmithKline Intellectual Property Development Limited Gepotidacin for use in the treatment of bacterial urinary tract infections
US20220257615A1 (en) * 2019-07-05 2022-08-18 Glaxosmithkline Intellectual Property Development Limied Combination for the treatment of infections caused by mycoplasma genitalium
JP2023528560A (ja) 2020-04-02 2023-07-05 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド ゲポチダシンを用いて淋菌感染症を治療するためのレジメン
WO2021219637A1 (en) 2020-04-29 2021-11-04 Glaxosmithkline Intellectual Property Development Limited Crystalline forms of gepotidacin
CN111494241B (zh) * 2020-06-01 2023-03-24 湖北洁世达环保科技有限公司 一种纸巾柔润保湿液
EP4288035A1 (en) * 2021-02-05 2023-12-13 GlaxoSmithKline Intellectual Property Development Limited Oral solid dose formulations
EP4465989A1 (en) 2022-01-21 2024-11-27 GlaxoSmithKline Intellectual Property Development Limited Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus saprophyticus
EP4316463A1 (en) 2022-08-02 2024-02-07 GlaxoSmithKline Intellectual Property Development Limited Novel formulation
JP2025532252A (ja) 2022-09-26 2025-09-29 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド 処置方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403610B1 (en) * 1999-09-17 2002-06-11 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
US6525049B2 (en) * 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
US6624159B2 (en) * 2000-07-12 2003-09-23 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
DE60125373T2 (de) * 2000-07-26 2007-10-18 Smithkline Beecham P.L.C., Brentford Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
US6603005B2 (en) * 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
EP1345903A1 (en) * 2000-12-21 2003-09-24 Ciba SC Holding AG Crystalline forms of cerivastatin sodium
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
US6602884B2 (en) 2001-03-13 2003-08-05 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
GB0112836D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
AU2002350217A1 (en) * 2001-12-04 2003-06-17 Bristol-Myers Squibb Company Glycinamides as factor xa inhibitors
WO2003064431A2 (en) * 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
WO2003064421A1 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine derivatives
AR040335A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
TW200409637A (en) * 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
AU2003301414B8 (en) * 2002-10-10 2010-06-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Novel compounds with antibacterial activity
DE60331849D1 (de) * 2002-11-05 2010-05-06 Glaxosmithkline Llc Antibakterielle wirkstoffe
AU2003291227A1 (en) * 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
TW200427688A (en) * 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
TW200507841A (en) * 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
US7232833B2 (en) * 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US7348434B2 (en) * 2003-08-08 2008-03-25 Antony Bigot 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2867472B1 (fr) 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
US7691850B2 (en) * 2004-06-15 2010-04-06 Glaxo Group Limited Antibacterial agents
FR2872164B1 (fr) * 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
EP1773831A1 (en) 2004-07-08 2007-04-18 Glaxo Group Limited Antibacterial agents
WO2006010040A2 (en) * 2004-07-09 2006-01-26 Glaxo Group Limited Antibacterial agents
EP1773343A4 (en) * 2004-07-13 2009-05-13 Glaxo Group Ltd ANTIBACTERIAL AGENTS
US20070270417A1 (en) 2004-07-22 2007-11-22 Glaxo Group Limited Antibacterial Agents
DE602005024151D1 (de) * 2004-08-02 2010-11-25 Glaxo Group Ltd Antibakterielle mittel
US20070161627A1 (en) * 2004-08-09 2007-07-12 Miller William H Antibacterial agents
DE102004041163A1 (de) * 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
JP4887297B2 (ja) 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
ATE466857T1 (de) * 2004-10-05 2010-05-15 Actelion Pharmaceuticals Ltd Neue piperidin-antibiotika
WO2006046552A1 (ja) 2004-10-27 2006-05-04 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
WO2006081178A2 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006081179A1 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
US7605169B2 (en) * 2005-01-25 2009-10-20 Glaxo Group Limited Antibacterial agents
WO2006081289A2 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006081182A2 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006099884A1 (en) 2005-03-24 2006-09-28 Actelion Percurex Ag Beta-aminoalcohol antibiotics
EP1863483A4 (en) 2005-03-31 2010-03-31 Janssen Pharmaceutica Nv Bicyclic pyrazole compounds as anti-bacteriostatic agents
AU2006250987A1 (en) * 2005-05-24 2006-11-30 Astrazeneca Ab Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
EP1888574B1 (en) * 2005-05-25 2009-09-02 Actelion Pharmaceuticals Ltd. New antibiotic derivatives
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (en) 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
EP1954697B1 (en) * 2005-10-21 2010-02-24 Glaxo Group Limited Peri condensed tricyclic compounds useful as antibacterial agents
US20070185153A1 (en) * 2005-12-22 2007-08-09 Nathalie Cailleau Compounds
EP2001887B1 (en) * 2006-04-06 2010-09-15 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
EP2007377A4 (en) * 2006-04-06 2011-08-17 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
GB0608263D0 (en) * 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
US20100256124A1 (en) * 2006-06-09 2010-10-07 David Thomas Davies Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
GB0705672D0 (en) * 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP1980251A1 (en) * 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
GB0707708D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
GB0707706D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2005995A1 (en) * 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
GB0800367D0 (en) * 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
PE20090274A1 (es) 2009-04-03
NZ579877A (en) 2011-09-30
MY149347A (en) 2013-08-30
BRPI0810064B1 (pt) 2021-03-30
IL201204A0 (en) 2010-05-17
CL2008001122A1 (es) 2008-10-24
TW200848420A (en) 2008-12-16
PT2137196E (pt) 2010-12-16
US8389524B2 (en) 2013-03-05
EP2137196A1 (en) 2009-12-30
CN101687887A (zh) 2010-03-31
AU2008240764C1 (en) 2011-10-20
AU2008240764B2 (en) 2011-04-07
BRPI0810064A2 (pt) 2019-08-27
TWI431006B (zh) 2014-03-21
CY1111248T1 (el) 2015-06-11
KR101567096B1 (ko) 2015-11-06
JP5389013B2 (ja) 2014-01-15
DK2137196T3 (da) 2011-01-10
MX2009011317A (es) 2009-11-05
HK1138000A1 (en) 2010-08-13
AU2008240764A1 (en) 2008-10-30
BRPI0810064B8 (pt) 2021-05-25
ATE483717T1 (de) 2010-10-15
HRP20100574T1 (hr) 2010-12-31
UY31038A1 (es) 2008-11-28
AR066111A1 (es) 2009-07-22
MA31324B1 (fr) 2010-04-01
CA2684659C (en) 2015-11-24
PL2137196T3 (pl) 2011-03-31
CR20150586A (es) 2016-04-04
CR11123A (es) 2010-03-08
CA2684659A1 (en) 2008-10-30
CN101687887B (zh) 2012-08-29
EA015821B1 (ru) 2011-12-30
KR20100017133A (ko) 2010-02-16
JP2010524884A (ja) 2010-07-22
EP2137196B1 (en) 2010-10-06
WO2008128942A1 (en) 2008-10-30
DE602008002912D1 (de) 2010-11-18
US20100137282A1 (en) 2010-06-03
EA200970987A1 (ru) 2010-04-30
CO6251368A2 (es) 2011-02-21
DOP2009000240A (es) 2009-12-31

Similar Documents

Publication Publication Date Title
SI2137196T1 (sl) Tricikliäśne spojine, ki vsebujejo duĺ ik, uporabne kot antibakterijska sredstva
BRPI0815717A2 (pt) Compostos de imidazopirazina.
SMT201500117B (it) Composti antibatterici
DK2139494T3 (da) Farmaceutiske formuleringer, der indeholder dapagliflozin-propylenglycolhydrat
BRPI0923786A2 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
BRPI0815067A2 (pt) Compostos de biciclotactama substituída
BRPI0813245A2 (pt) Escova de dentes.
SI1976506T1 (sl) Rastlinski izvlečki, ki vsebujejo kanabinoide kot nevrozaščitna sredstva
BRPI0814745A2 (pt) Composição de produto.
BRPI0810646A2 (pt) " compostos farmacêuticos ".
BRPI0815042A2 (pt) Compostos de pirazol
BRPI0821402A2 (pt) Frasco de perfume
BR112012028519A2 (pt) compostos de 2,5,6,7-tetrahidro-[1,4]oxazepin-3-ilamina ou 2,3,6,7-tetrahidro-[1,4]oxazepin-5-ilamina
BRPI0810191A2 (pt) Escova de dentes
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
DK2151438T3 (da) Lægemiddel indeholdende PPAR-Deltaagonist
IL202546A0 (en) Prolonged effect disinfectant cleanser
SI3090730T1 (sl) Tablete, ki vsebujejo eltrombopag olamin
BRPI0811718A2 (pt) Derivados de 3,3-espiroindolinona
BRPI0821627A2 (pt) Compostos químicos
BRPI0814601A2 (pt) compostos químicos
BRPI0812288A2 (pt) Purificação de imunoglobulina.
BRPI0813966A2 (pt) Usos de mdl-1
BRPI0907108A2 (pt) escova de dentes.
DK2235041T3 (da) Antimikrobielle forbindelser